• By ICR Secretariat
  • Posted Wednesday, April 10, 2019

Lyrica reclassified after being linked to 33 deaths

http://www.pharmatimes.com/news/lyrica_to_become_class_c_drug_after_being_linked_to_33_deaths_1283252

Pfizer's Lyrica (pregabalin) is to be reclassified following concerns over misuse.

On the back of a public consultation and advice from the Advisory Council on the Misuse of Drugs, the drug known on the street as ‘buds’ will be reclassified as a class C controlled substance from April.